Royalty Pharma (NASDAQ:RPRX) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.21 by 7.44 percent. This is a 22.64 percent increase over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $631.000 million which missed the analyst consensus estimate of $1.235 billion by 48.91 percent. This is a 11.09 percent increase over sales of $568.000 million the same period last year.